Alto Neuroscience, Inc. Common Stock (ANRO)
Operating Cash Flow (Statement)
-$68.29M
TTM · Period ending: · USD
ANRO Operating Cash Flow (Statement)
Latest reported-$68.29Mperiod ending
Latest reported-$68.29Mperiod ending
ANRO Cash from Operations (-$9.26M → -$68.29M)
Annual operating cash flow (statement)
High-resolution chart · PNG
ANRO operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -51,769,000 | |
| -47,424,000 | |
| -33,448,000 | |
| -20,394,000 | |
| -9,262,000 |